Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-04, Stock:ABBV, The news for the past five days is as follows:
2019-05-28: NEWS1: Gilead Sciences Slips on Goldman's Downgrade to Sell.NEWS2: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS3: This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy.NEWS4: J&J Stock Up This Year So Far: Will the Momentum Continue?.NEWS5: J&J Stock Up This Year So Far: Will the Momentum Continue?.NEWS6: J&J Stock Up This Year So Far: Will the Momentum Continue?.NEWS7: This 5% Dividend Yield Isn't Good Enough for Me.NEWS8: This 5% Dividend Yield Isn't Good Enough for Me.
2019-05-29: nan
2019-05-30: NEWS1: 3 Top Gene Therapy Stocks That Could Soar.NEWS2: 3 Top Gene Therapy Stocks That Could Soar.NEWS3: 3 Top Gene Therapy Stocks That Could Soar.NEWS4: The Inverted Yield Curve Should Make Investors Pivot, Not Panic.NEWS5: The Inverted Yield Curve Should Make Investors Pivot, Not Panic.NEWS6: Notable ETF Inflow Detected - DGRO, ABBV, UTX, BMY.NEWS7: Notable ETF Inflow Detected - DGRO, ABBV, UTX, BMY.NEWS8: The Inverted Yield Curve Should Make Investors Pivot, Not Panic.NEWS9: AbbVie Presents Results from Several Studies and Clinical Trials Investigating Medicines Across More than 15 Cancers at the 2019 ASCO and EHA Meetings.NEWS10: AbbVie's MAVIRET™ now listed in New Brunswick.
2019-05-31: NEWS1: Notable Friday Option Activity: MSFT, ABBV, LRCX.NEWS2: Notable Friday Option Activity: MSFT, ABBV, LRCX.NEWS3: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS4: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS5: Vertex Selects Triple Combo Regimen for Regulatory Submission.NEWS6: Vertex Selects Triple Combo Regimen for Regulatory Submission.NEWS7: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS8: Comparing AbbVie’s and Amgen’s 2019 Revenue Growth Trajectories.NEWS9: Vertex Selects Triple Combo Regimen for Regulatory Submission.
2019-06-03: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.

Answer: Rise